Background: Blood transfusions are banned by the World Anti-Doping Agency as a form of "blood doping". A method of detection of homologous blood transfusion (HBT) has been implemented by the accredited anti-doping laboratories worldwide; however, no internationally recognized method has been finalized so far for the direct detection of autologous blood transfusions, which can at present be revealed only by targeted longitudinal profiling of key blood parameters.
Detecting autologous blood transfusion in doping control: biomarkers of blood aging and storage measured by flow cytofluorimetry / Donati, F; Acciarini, Roberta; De Benedittis, Ilenia; de la Torre, Xavier; Pirri, Daniela; Prete, Mariangela; Stampella, Alessandra; Vernucci, Enza; Botre, Francesco. - In: CURRENT PHARMACEUTICAL BIOTECHNOLOGY. - ISSN 1873-4316. - STAMPA. - (2018). [10.2174/1389201019666180405165118]
Detecting autologous blood transfusion in doping control: biomarkers of blood aging and storage measured by flow cytofluorimetry
Botre, Francesco
2018
Abstract
Background: Blood transfusions are banned by the World Anti-Doping Agency as a form of "blood doping". A method of detection of homologous blood transfusion (HBT) has been implemented by the accredited anti-doping laboratories worldwide; however, no internationally recognized method has been finalized so far for the direct detection of autologous blood transfusions, which can at present be revealed only by targeted longitudinal profiling of key blood parameters.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Donati_Detecting-Autologous_2018.pdf
Accesso chiuso
Licenza:
Tutti i diritti riservati
Dimensione
2.25 MB
Formato
Adobe PDF
|
2.25 MB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
